Nebenwirkungen · Accofil
Accofil 70 MU/0.73 ml solution for injection/infusion in pre-filled syringe · Abschnitt 4.8 · PDF-Seite 68
HOS-222021 · Präparat HOS-216908
The most serious adverse reactions that may occur during Filgrastim treatment include: anaphylactic reaction, serious pulmonary adverse events (including interstitial pneumonia and ARDS), capillary leak syndrome, severe splenomegaly/splenic rupture, transformation to myelodysplastic syndrome or leukaemia in SCN patients, GvHD in patients receiving allogeneic bone marrow transfer or peripheral blood cell progenitor cell transplant and sickle cell crisis in patients with sickle cell disease.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2025-11-25T15:11:00Z · SHA-256 c3518f7b95bc3dd24963f91afa5cd0272badfcd4a5f8943510b2f417086a82ed · Passage 14f60e1c9e2b19068741d1a26c1784fb85de2ae24ae70eaaf95ce74293fa581c · Zeichen 34–528 im Abschnitt